Martingale Asset Management L P Deciphera Pharmaceuticals, Inc. Transaction History

Martingale Asset Management L P

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.58 - $17.36 $8,148 - $10,416	-600 Reduced 0.85%	69,926 $1.1 Million
Q4 2023 Feb 12, 2024	BUY	$10.11 - $16.54 $50 - $82	5 Added 0.01%	70,526 $1.14 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $39,423 - $48,978	-3,164 Reduced 4.29%	70,521 $897,000
Q2 2023 Aug 11, 2023	BUY	$13.28 - $15.96 $220,965 - $265,558	16,639 Added 29.17%	73,685 $1.04 Million
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $399 - $618	28 Added 0.05%	57,046 $881,000
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $416,676 - $534,243	28,059 Added 96.89%	57,018 $934,000
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $126,387 - $206,528	-10,209 Reduced 26.06%	28,959 $536,000
Q2 2022 Aug 11, 2022	SELL	$9.11 - $13.98 $108,336 - $166,250	-11,892 Reduced 23.29%	39,168 $515,000
Q1 2022 May 12, 2022	BUY	$6.87 - $11.11 $105,825 - $171,138	15,404 Added 43.2%	51,060 $473,000
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $229,067 - $1.1 Million	29,749 Added 503.62%	35,656 $348,000
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $79 - $111	3 Added 0.05%	5,907 $200,000
Q2 2021 Aug 13, 2021	BUY	$32.73 - $47.95 $193,237 - $283,096	5,904 New	5,904 $216,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.